Search - tctmd.com

Displaying 221 - 238 of 238

Sort: Relevancy | Date

Presentation THT 2022

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Presenter: Waleed Al-Darzi

February 02, 2022

Presentation THT 2022

Clinical Data and Patient Experience with Barostim

Presenter: Nirav Raval

February 02, 2022

Presentation THT 2022

Alleviant Medical Technology, Procedure and Clinical Data

Presenter: Colin Barker

February 02, 2022

Presentation THT 2022

Mechanism of Action of Baroreflex Activation Therapy

Presenter: Marat Fudim

February 02, 2022

Presentation THT 2022

Clinical Data and Landscape of Interatrial Shunting

Presenter: Peter Fail

February 02, 2022

Presentation THT 2022

The Need for Device Therapy in HFrEF

Presenter: William Abraham

February 02, 2022

Presentation THT 2022

The Clinical Story of CCM® – Looking ahead to HFpEF Population

Presenter: Javed Butler

February 02, 2022

Presentation THT 2022

Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Evaluating clinical findings to support earlier diagnosis and management

Presenter: Gregg Lanier

February 01, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Presentation THT 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presenter: Barry Greenberg

February 01, 2022

Presentation THT 2022

Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Recovered EF Heart Failure -- Physiology, Clinical Implications, and Treatment

Presenter: Douglas Mann

February 01, 2022

Presentation THT 2022

Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines

Presenter: Milton Packer

February 01, 2022

Presentation THT 2022

Omecamtiv Mecarbil - Is It More Effective in Low EFs

Presenter: John Teerlink

February 01, 2022

Presentation THT 2022

Secubitirl-Valsartan Across the Spectrum of EFs

Presenter: Scott Solomon

February 01, 2022

Presentation THT 2022

Vericiguat

Presenter: Javed Butler

February 01, 2022

Presentation THT 2022

SGLT2 Inhibitors: What the Clinician Should Know

Presenter: Stefan Anker

February 01, 2022

Presentation THT 2022

Spectrum of SGLT2-Inhibitor Benefits: Clinical to Symptoms to Quality of Life

Presenter: Javed Butler

February 01, 2022

Advertisement

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Clinical Data and Patient Experience with Barostim

Alleviant Medical Technology, Procedure and Clinical Data

Mechanism of Action of Baroreflex Activation Therapy

Clinical Data and Landscape of Interatrial Shunting

The Need for Device Therapy in HFrEF

The Clinical Story of CCM® – Looking ahead to HFpEF Population

Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Evaluating clinical findings to support earlier diagnosis and management

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF

Recovered EF Heart Failure -- Physiology, Clinical Implications, and Treatment

Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines

Omecamtiv Mecarbil - Is It More Effective in Low EFs

Secubitirl-Valsartan Across the Spectrum of EFs

Vericiguat

SGLT2 Inhibitors: What the Clinician Should Know

Spectrum of SGLT2-Inhibitor Benefits: Clinical to Symptoms to Quality of Life

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content